{"id":16910,"date":"2024-09-29T10:08:56","date_gmt":"2024-09-29T08:08:56","guid":{"rendered":"https:\/\/inmuno.es\/?page_id=16910"},"modified":"2024-09-29T10:08:56","modified_gmt":"2024-09-29T08:08:56","slug":"trends-in-immunology","status":"publish","type":"page","link":"https:\/\/inmuno.es\/index.php\/trends-in-immunology\/","title":{"rendered":"Trends in Immunology"},"content":{"rendered":"<ul class=\"wp-block-latest-posts__list is-grid columns-3 has-dates has-author wp-block-latest-posts\"><li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/inmuno.es\/index.php\/2026\/05\/02\/outcome-measures-in-systemic-lupus-erythematosus\/\">Outcome measures in systemic lupus erythematosus<\/a><div class=\"wp-block-latest-posts__post-author\">by inmunoadmin<\/div><time datetime=\"2026-05-02T06:53:47+02:00\" class=\"wp-block-latest-posts__post-date\">2 de May de 2026<\/time><div class=\"wp-block-latest-posts__post-excerpt\">Curr Opin Immunol. 2026 Apr 30;100:102782. doi: 10.1016\/j.coi.2026.102782. Online ahead of print. ABSTRACT Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease characterized by fluctuating multisystem involvement, relapsing-remitting activity, and substantial risk of irreversible organ damage. Standardized disease activity indices have facilitated clinical trials and research, yet integration into clinical practice has not occurred for &#8230; <a title=\"Outcome measures in systemic lupus erythematosus\" class=\"read-more\" href=\"https:\/\/inmuno.es\/index.php\/2026\/05\/02\/outcome-measures-in-systemic-lupus-erythematosus\/\" aria-label=\"Read more about Outcome measures in systemic lupus erythematosus\">Read more<\/a><\/div><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/inmuno.es\/index.php\/2026\/05\/02\/scaling-immunity-sickness-as-a-host-defense-strategy-a-clare-sparling\/\">Scaling immunity: sickness as a host defense strategy. A Clare Sparling<\/a><div class=\"wp-block-latest-posts__post-author\">by inmunoadmin<\/div><time datetime=\"2026-05-02T06:53:43+02:00\" class=\"wp-block-latest-posts__post-date\">2 de May de 2026<\/time><div class=\"wp-block-latest-posts__post-excerpt\">Trends Immunol. 2026 Apr 30:S1471-4906(26)00076-1. doi: 10.1016\/j.it.2026.03.015. Online ahead of print. ABSTRACT Sickness, or sickness behavior, is a state of altered physiology and behavior generated by the brain-immune axis during infection, which is generally assumed to contribute to host defense. Here, we examine this assumption by framing sickness as organismal-scale immunity and explore predicted parallels &#8230; <a title=\"Scaling immunity: sickness as a host defense strategy. A Clare Sparling\" class=\"read-more\" href=\"https:\/\/inmuno.es\/index.php\/2026\/05\/02\/scaling-immunity-sickness-as-a-host-defense-strategy-a-clare-sparling\/\" aria-label=\"Read more about Scaling immunity: sickness as a host defense strategy. A Clare Sparling\">Read more<\/a><\/div><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.nature.com\/articles\/s41577-026-01306-1\">Freedom of scientific inquiry: reclaiming space for controversy<\/a><div class=\"wp-block-latest-posts__post-author\">by Akiko Iwasaki<\/div><time datetime=\"2026-05-01T16:00:00+02:00\" class=\"wp-block-latest-posts__post-date\">1 de May de 2026<\/time><div class=\"wp-block-latest-posts__post-excerpt\">\n                Nature Reviews Immunology, Published online: 01 May 2026; doi:10.1038\/s41577-026-01306-1No matter how small the possibility, or how inconvenient the topic, scientists must maintain the humility to acknowledge that we could be wrong. Ou&#8230;<\/div><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.science.org\/doi\/abs\/10.1126\/sciimmunol.aei2832?af=R\">B cells gone broad: A deep dive into SARS-CoV-2 antibody breadth<\/a><div class=\"wp-block-latest-posts__post-author\">by Easton E. Ford and Melissa L. Smith<\/div><time datetime=\"2026-05-01T09:00:00+02:00\" class=\"wp-block-latest-posts__post-date\">1 de May de 2026<\/time><div class=\"wp-block-latest-posts__post-excerpt\">Science Immunology, Volume 11, Issue 119, May 2026. <\/div><\/li>\n<li><a class=\"wp-block-latest-posts__post-title\" href=\"https:\/\/www.science.org\/doi\/abs\/10.1126\/sciimmunol.aei2411?af=R\">A parasite partner for regulatory affairs<\/a><div class=\"wp-block-latest-posts__post-author\">by Isabella O. Conway and Christopher A. Hunter<\/div><time datetime=\"2026-05-01T09:00:00+02:00\" class=\"wp-block-latest-posts__post-date\">1 de May de 2026<\/time><div class=\"wp-block-latest-posts__post-excerpt\">Science Immunology, Volume 11, Issue 119, May 2026. <\/div><\/li>\n<\/ul>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":16911,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-16910","page","type-page","status-publish","has-post-thumbnail"],"_links":{"self":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/pages\/16910","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/comments?post=16910"}],"version-history":[{"count":1,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/pages\/16910\/revisions"}],"predecessor-version":[{"id":16912,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/pages\/16910\/revisions\/16912"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media\/16911"}],"wp:attachment":[{"href":"https:\/\/inmuno.es\/index.php\/wp-json\/wp\/v2\/media?parent=16910"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}